JESSICA RAYNER: Open Payments
NPI 1679000525 · EAST CHICAGO, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$901 in 43 payments from 12 companies in 2025. Trend: 2023 $845 · 2024 $1,017 · 2025 $901
Food & beverage: $850Long term medical supply or device loan: $51
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 15 | $227 |
| Amgen Inc. | 10 | $194 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 4 | $134 |
| Boston Scientific Corporation | 2 | $72 |
| SCPHARMACEUTICALS INC. | 3 | $69 |
| Baxter Healthcare | 1 | $51 |
| E.R. Squibb & Sons, L.L.C. | 2 | $36 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| Novo Nordisk Inc | 1 | $26 |
| Edwards Lifesciences Corporation | 1 | $20 |
Products named: LEQVIO, REPATHA, LifeVest, WATCHMAN FLX, FUROSCIX, Hillrom - ELI 280, CAMZYOS, Wegovy.
Industry payments across IN — which companies pay providers there.
